(83 days)
No
The summary describes a computer-assisted surgical system using electromagnetic tracking for localization and positioning. There is no mention of AI, ML, or related concepts in the intended use, device description, or performance studies. The software validation focuses on standard functional and safety testing.
No
The device is an intraoperative image guided localization system used to aid surgeons with drill positioning. It does not directly treat a disease or condition.
No
Explanation: The device is described as an "intraoperative image guided localization system" and a "computer assisted orthopedic surgery tool to aid the surgeon with drill positioning for screws," which provides "information to the surgeon that is used to place surgical instruments during surgery." It assists in locating and positioning screws, rather than diagnosing a condition or disease.
No
The device description explicitly states it is a "computer controlled electromagnetic tracking system" and mentions hardware components like a "targeter" and "trauma interfaces" which are part of the system. While software is a component, the device is not solely software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's an "intraoperative image guided localization system" and a "computer assisted orthopedic surgery tool to aid the surgeon with drill positioning for screws during intramedullary nail implantation." This describes a surgical guidance system used during a procedure, not a device used to examine specimens in vitro (outside the body) to diagnose or monitor a condition.
- Device Description: The description focuses on electromagnetic tracking technology used to determine the 3D position of surgical instruments. This is consistent with a surgical navigation or guidance system, not an IVD.
- Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing diagnostic information based on laboratory tests
- Mentioning reagents, assays, or laboratory procedures
The device's function is to assist the surgeon with precise instrument placement during surgery based on real-time tracking data, which falls under the category of surgical guidance or navigation systems, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The Smith & Nephew SURESHOT™ Targeting System is intended to be an intraoperative image guided localization system. It is a computer assisted orthopedic surgery tool to aid the surgeon with drill positioning for screws during intramedullary nail implantation. It provides information to the surgeon that is used to place surgical instruments during surgery utilizing intraoperatively obtained electromagnetic tracking data. The Smith & Nephew SURESHOT™ Targeting System is indicated for long bone fracted with intramedullary nails in which the use of stereotactic surgery may be appropriate.
Product codes
OLO
Device Description
Subject of this premarket notification are modifications to the SURESHOT™ Distal Targeting System V4.0- targeter which has been designed with a reduced size and weight compared to the previous design of the targeter (K092497). The SURESHOT Targeting system targeter is intended to be used the SURESHOT trauma interfaces (K170977, K100107) and software V4.0 (K170280).
The SURESHOT™ Targeting System is a computer controlled electromagnetic tracking system. It assists the surgeon in locating and positioning screws in an intramedullary nail implant during orthopedic trauma surgery. The link between the sterile surgical area (patient) and the instrument system is provided through an electromagnetic tracking system. Electromagnetic spatial measurement systems determine the location of instruments that are embedded with sensor coils. When the sensor-embedded instrument is placed inside controlled, varying magnetic fields, voltages are induced in the sensor coils. These induced voltages are used by the measurement system to calculate a 3D virtual position of the instrument. Because the magnetic fields are of low field strength and can safely pass through human tissue, location measurement of an object is possible without the line-of-sight constraints of an optical spatial measurement system that requires a camera.
The SURESHOT™ Distal Targeting System V4.0 targeter is intended to be used with existing Smith & Nephew software, trauma interface, instruments and implants, No new instruments or implants are being cleared via this premarket notification.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
intraoperatively obtained electromagnetic tracking data
Anatomical Site
long bone fractures
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgeon / intraoperative
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Pre-clinical testing of the SURESHOT™ Distal Targeting System V4.0 targeter included Electromagnetic compatibility and electrical safety validation testing, specifically IEC 606061-1-2:2007 Class A for Emissions, Immunity for Non Life . Supporting Equipment, and IEC 60601-1: 2005 + A1 :2012 Medical Electrical Equipment Part 1: General . Requirements for Safety. These tests demonstrated the device meets application performance requirements. Software verification and validation testing was completed according to FDA guidance, including tests for Software Validation and Verification Report, Deployment Distal Targeting Software, Workflow and System Settings, Tool Connections, Sleeve Selection, Implant Selection, Drilling Screen, Hardware Failure, Drill Depth Measurement, Targeting Calculations (META, TAN/FAN, Humeral, Field Check, META-TAN), Translations (Chinese, English, French, German, Italian, Japanese, Portuguese, Finnish, Spanish), Nail Rotation, View Selection, Customer Validation, and Regression Test. No clinical data was needed to support safety and effectiveness.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The FDA logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. The Department of Health & Human Services logo is a stylized image of a human figure.
April 24, 2018
Smith & Nephew, Inc. Brad Sheals Regulatory Affairs Manager 7135 Goodlett Farms Parkway Cordova, Tennessee 38016
Re: K180277
Trade/Device Name: Smith & Nephew SURESHOT Distal Targeting System V4.0 Targeter Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: March 23, 2018 Received: March 26, 2018
Dear Brad Sheals:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K180277
Device Name
Smith & Nephew SURESHOT Distal Targeting System V4.0
Indications for Use (Describe)
The Smith & Nephew SURESHOT™ Targeting System is intended to be an intraoperative image guided localization system. It is a computer assisted orthopedic surgery tool to aid the surgeon with drill positioning for screws during intramedullary nail implantation. It provides information to the surgeon that is used to place surgical instruments during surgery utilizing intraoperatively obtained electromagnetic tracking data. The Smith & Nephew SURESHOT™ Targeting System is indicated for long bone fracted with intramedulary nails in which the use of stereotactic surgery may be appropriate.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image features the Smith & Nephew logo. The logo consists of an orange star-like symbol on the left, followed by the text "We are" in gray. To the right of that, the words "smith&nephew" are written in orange.
| Submitted by: | Smith & Nephew, Inc.
Advanced Surgical Devices Division
1450 East Brooks Road
Memphis, Tennessee 38116 |
|----------------------------------------------|-----------------------------------------------------------------------------------------------------------------|
| Date of Summary: | April 20, 2018 |
| Contact Person and Address: | Brad Sheals
Regulatory Affairs Manager
T 901-399-6897 |
| Name of Device: | Smith & Nephew, Inc. SURESHOT™ Distal
Targeting System V4.0 |
| Common Name: | Computer Assisted Surgery System |
| Device Classification Name
and Reference: | 21 CFR 882.4560 Stereotaxic Instrument |
| Device Class: | Class II |
| Panel Code: | Neurology/84 |
| Product Code: | OLO |
Device Description
Subject of this premarket notification are modifications to the SURESHOT™ Distal Targeting System V4.0- targeter which has been designed with a reduced size and weight compared to the previous design of the targeter (K092497). The SURESHOT Targeting system targeter is intended to be used the SURESHOT trauma interfaces (K170977, K100107) and software V4.0 (K170280).
The SURESHOT™ Targeting System is a computer controlled electromagnetic tracking system. It assists the surgeon in locating and positioning screws in an intramedullary nail implant during orthopedic trauma surgery. The link between the sterile surgical area (patient) and the instrument system is provided through an electromagnetic tracking system. Electromagnetic spatial measurement systems determine the location of instruments that are embedded with sensor coils. When the sensor-embedded instrument is placed inside controlled, varying magnetic fields, voltages are induced in the sensor coils. These induced voltages are used by the measurement system to calculate a 3D virtual position of the instrument. Because the magnetic fields are of low field strength and can safely pass through human tissue, location measurement of an object is possible without the line-of-sight constraints of an optical spatial measurement system that requires a camera.
The SURESHOT™ Distal Targeting System V4.0 targeter is intended to be used with existing Smith & Nephew software, trauma interface, instruments and implants, No new instruments or implants are being cleared via this premarket notification.
4
Indications for Use
The Smith & Nephew SURESHOT™ Targeting System is intended to be an intraoperative image guided localization system. It is a computer assisted orthopedic surgery tool to aid the surgeon with drill positioning for screws during intramedullary nail implantation. It provides information to the surgeon that is used to place surgical instruments during surgery utilizing intraoperatively obtained electromagnetic tracking data. The Smith & Nephew SURESHOT™ Targeting System is indicated for long bone fractures treated with intramedullary nails in which the use of stereotactic surgery may be appropriate.
Comparison to Technological Characteristics with the Predicate Device
Device comparisons described in this premarket notification demonstrated that the proposed SURESHOT™ Targeting System is equivalent to the legally marketed predicate devices cleared in the below table with regard to intended use, indications for use, and performance characteristics.
The subject devices feature characteristics as previously cleared in K092497 with the primary differences being the reduced size and weight.
Summary of Pre-Clinical Testing
Electromagnetic compatibility and electrical safety validation testing has been conducted on the SURESHOT™ Distal Targeting System. The SURESHOT Distal Targeting System V4.0 targeter is used with the trauma interface. The subject device generates the same electromagnetic tracking technology as the existing targeter cleared in PiGalileo Screw Targeting System V1.1. The electromagnetic capability and electrical safety testing that was conducted includes.
- IEC 606061-1-2:2007 Class A for Emissions, Immunity for Non Life . Supporting Equipment
- IEC 60601-1: 2005 + A1 :2012 Medical Electrical Equipment Part 1: General . Requirements for Safety.
Results of the electromagnetic compatibility and electrical safety validation testing demonstrate the device is found to meet the application performance requirements to those standards.
Software verification and validation testing was completed in line with FDA's guidance document entitled, "General Principles of Software Validation; Final Guidance for Industry and FDA Staff," dated January 11, 2002. Preclinical testing included the following tests:
- 12.102 Software Validation and Verification Report ●
- 12.201 Deployment Distal Targeting Software ●
- 12.301 Workflow and System Settings ●
- 12.302 Tool Connections ●
- . 12.303 Sleeve Selection
5
- 12.304 Implant Selection ●
- . 12.305 Drilling Screen
- 12.306 Hardware Failure .
- 12.307 Drill Depth Measurement
- 12.308 Targeting Calculations META ●
- 12.309 Targeting Calculations TAN/FAN ●
- 12.310 Targeting Calculations Humeral ●
- 12.311 Targeting Calculations Field Check ●
- 12.312 Targeting Calculations META-TAN
- 12.313 Translations Chinese
- 12.314 Translations English
- 12.315 Translations French ●
- 12.316 Translations German ●
- 12.317 Translations Italian ●
- 12.318 Translations Japanese ●
- 12.319 Translation Portuguese ●
- 12.320 Translation Finnish ●
- 12.321 Translation Spanish
- 12.322 Nail Rotation ●
- 12.323 View Selection ●
- 12.401 Customer Validation ●
- 12.402 Regression Test ●
A review of this testing has demonstrated that there are no new issues related to the safety and effectiveness of the subject device and the software will perform as intended as compared to the predicate. Clinical data was not needed to support the safety and effectiveness of the subject device.
Substantial Equivalence Information
The substantial equivalence of the SURESHOT™ Targeting System V4.0 - targeter is based on its similarities in indications for use, design features, sterilization methods and operational principles to the predicate systems listed in the following table.
| Manufacturer | Description | Submission
Number | Clearance
Date |
|-------------------|------------------------------------------|----------------------|-----------------------|
| Smith &
Nephew | PiGalileo Screw Targeting
System V1.1 | K092497 | September 11,
2009 |
Table 5.1: Substantially Equivalent Predicate Systems to SURESHOT™ Targeting System
6
| Design Aspect Reviewed | SURESHOT ™ Distal Targeting System
V4.0-Targeter | PiGalileo Screw Targeting System V1.1 |
|-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Number | Subject device | K092497 |
| Manufacturer | Smith & Nephew | Smith & Nephew |
| Similar Indications for Use | The Smith & Nephew SURESHOT™
Targeting System is intended to be an
intraoperative image guided localization
system. It is a computer assisted
orthopedic surgery tool to aid the surgeon
with drill positioning for screws during
intramedullary nail implantation. It
provides information to the surgeon that is
used to place surgical instruments during
surgery utilizing intraoperatively obtained
electromagnetic tracking data. The Smith
& Nephew SURESHOT™ Targeting
System is indicated for long bone fractures
treated with intramedullary nails in which
the use of stereotactic surgery may be
appropriate. | The Smith & Nephew PiGalileo Screw
Targeting System is intended to be an
intraoperative image guided localization
system. It is a computer assisted
orthopedic surgery tool to aid the surgeon
with drill positioning for screws during
intramedullary nail implantation. It provides
information to the surgeon that is used to
place surgical instruments during surgery
utilizing intraoperatively obtained
electromagnetic tracking data. The Smith
& Nephew PiGalileo Screw Targeting
System V1.1 is indicated for long bone
fractures treated with intramedullary nails
in which the use of stereotactic surgery
may be appropriate. |
| Intended Use | Intraoperative image guided localization system | |
| Instrumentation | Used to assist surgeon in placing nail implants and for specific use with the distal
targeting software | |
| Similar Sterilization | Y | Y |
| Similar Packaging | Y | Y |
| Similar Materialsf the | Y | Y |
| Similar Design | Y | Y |
| Overall Weight Targeter | ~750g | ~1kg |
A comparison of the subject device to the predicate device is described in the following table.
7
| Design Aspect Reviewed | SURESHOT ™ Distal Targeting System
V4.0-Targeter | PiGalileo Screw Targeting System V1.1 |
|------------------------|------------------------------------------------------------|----------------------------------------------------|
| Software Compatibility | SURSHOT Distal Targeting System V4.0
software (K170280) | PiGalileo Screw Targeting System V1.1
(K092497) |
Conclusion
The SURESHOT™ Distal Targeting System V4.0 targeter is substantially equivalent to the existing PiGalleo Screw Targeting System V1.1 handheld field generator (targeter) cleared in K092497 in that the indications for use for these devices are identical and the core technological principals for these devices are also equivalent.